Interleukin 17 regulates Mer tyrosine kinase-positive cells in Pseudomonas aeruginosa keratitis

Cui Li1, Sharon A McClellan2, Ronald Barrett2

  • 1Department of Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, Michigan, United States Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.

Abstract

Insights

Interleukin 17 (IL-17) levels influence Mer tyrosine kinase-positive (MerTK+) cells during Pseudomonas aeruginosa keratitis. Neutralizing IL-17 worsened disease in resistant mice but increased MerTK+ cells in susceptible mice.

Area of Science:

  • Ophthalmology
  • Immunology
  • Microbiology

Background:

  • Pseudomonas aeruginosa keratitis is a severe eye infection.
  • Interleukin 17 (IL-17) is a key cytokine in host defense and inflammation.
  • Mer tyrosine kinase (MerTK) plays a role in immune cell regulation.

Purpose of the Study:

  • To investigate the role of IL-17 in regulating MerTK-positive (MerTK+) cells during P. aeruginosa keratitis.
  • To compare IL-17 effects in susceptible (C57BL/6) and resistant (BALB/c) mouse models.

Main Methods:

  • Mice were infected with P. aeruginosa, and IL-17 levels were measured.
  • Recombinant IL-17 and IL-17 neutralizing antibodies were administered.
  • Clinical scores, inflammatory mediators (PCR, ELISA), and immune cell infiltration (MPO) were assessed.
  • MerTK+ cells were quantified using immunostaining and cell sorting.

Main Results:

  • IL-17 expression was higher in susceptible mice post-infection.
  • IL-17 neutralization exacerbated disease and increased myeloid cells in resistant mice.
  • IL-17 neutralization increased MerTK+ cells in susceptible mice but decreased them in resistant mice.

Conclusions:

  • IL-17 plays a differential role in regulating MerTK+ cells and disease severity in P. aeruginosa keratitis.
  • Modulating IL-17 offers potential therapeutic strategies for bacterial keratitis.